Insights on Clinical Trials
-
At-Home Clinical Trials: When At-Home Ophthalmic Exams Make Sense
12/23/2025
At-home ophthalmic exams in clinical trials improve patient accessibility, reduce site burden, and maintain data integrity, enabling decentralized research without sacrificing quality or compliance.
-
Hybrid Ophthalmic Trials: Splitting Visits Across Home, Hub, And Site
12/23/2025
Hybrid ophthalmic trials combine in-person and remote visits, boosting patient convenience, reducing site burden, and accelerating timelines while maintaining data quality and compliance.
-
Year-In-Review: Clinical Research Today And Tomorrow
12/10/2025
As the industry prepares for 2026, sponsors and investors alike face a pivotal moment — one that demands a more deliberate, insight-driven approach to early clinical development.
-
Europe At A Crossroads: Biotech Investment, Regulation, And Partnership In Real Life
12/10/2025
Position your biotech for Europe’s next phase by aligning strong science, smart clinical strategy, and the right global partners to navigate funding, regulation, and growth.
-
Overcoming Cell Therapy Design Challenges To Treat AML And Other Life-Threatening Diseases
12/9/2025
CERo CEO Chris Ehrlich discusses how a focus on safety, robust manufacturing, and key early indicators is rewriting the playbook for future personalized medicine trials.
-
Partnering With Health Systems: Essential Tips For CGT Commercialization
12/5/2025
Successful cell and gene therapy commercialization requires early, detailed manufacturer collaboration with health systems to ensure scalable operations and seamless patient access beyond the clinical trial.
-
Navigating The Challenges Of Cell Therapy Clinical Trials
12/5/2025
IN8bio CEO William Ho shares how they overcame operational challenges unique to cell therapy research, including how to carefully conduct site expansion and onboard new sites without disrupting study timelines.
-
Finding The Solution(s) That Meet The Needs Of Patients, Sites, And Sponsors
12/4/2025
Poor enrollment and retention often stem from patient burden and limited site access. Learn how leveraging diverse site networks and remote support can transform the clinical trial experience.
-
Guiding GLP-1 Participants Through The Challenge Of Retention
12/4/2025
Learn how remote lifestyle coaching can combat high dropout rates in metabolic research by offering the support participants need to maintain adherence and ensure data integrity.
-
Why Clinical Trial Demographics Don't Match Real-World Populations
12/4/2025
Representative trial demographics reduce bias, strengthen safety insights, and ensure therapies work for all. Learn why diversity is essential for accurate data and better health outcomes.